High Blood Pressure: This well-known hypertension drug recalled. If you hire him check the lot

Who I am
Elia Tabuenca García
@eliatabuencagarcia
Author and references

A drug was recalled, produced by the pharmaceutical company Mepha Pharma AG, widely used by those suffering from high blood pressure and heart problems. The lot affected by the recall

Don't store avocado like this: it's dangerous

If to keep the high pressure o treat heart problems use the drug Atenolol-Mepha®, be careful. Just recently, the Swiss pharmaceutical company Mepha Pharma AG has ordered the recall of one of the batches of the product as it contains a slightly lower amount of the active ingredient atenolol. Therefore, the effect on the body could be milder.





As also reported on the website of the Swiss Federal Council, the withdrawal concerns exclusively the production batch X15124F of Atenolol-Mepha® 25mg Lactab® 100, che shows the deadline deadline 07/2026.

If you have purchased the medicine in question - also prescribed to protect the heart muscle from overexertion (angina pectoris) - do not use it and contact your doctor for a possible replacement therapy. You can return it to the pharmacy and ask for a refund. Furthermore, for further information regarding the recall, you can contact the customer service of Mepha Pharma AG on 0800 00 33 88/061 705 43 43 or write an e-mail to kundendienst@mepha.ch

Follow us on Telegram | Instagram | Facebook | TikTok | Youtube

Fonte: Federal Bureau for Consumer Affairs (BFK) 

Read also:

  • Aifa withdraws well-known drug against hypertension: check the batches that have impurities
  • Aifa withdraws two batches of Losartan, a popular drug for hypertension: presence of impurities
  • Medicines and heat: the mistakes you could make in the summer (and that you must avoid)
  • 11 batches of diuretic and hypertension drugs withdrawn due to the presence of impurities
add a comment of High Blood Pressure: This well-known hypertension drug recalled. If you hire him check the lot
Comment sent successfully! We will review it in the next few hours.